[go: up one dir, main page]

MX9707008A - Uso de antiestrogenos para control natal en hombres. - Google Patents

Uso de antiestrogenos para control natal en hombres.

Info

Publication number
MX9707008A
MX9707008A MX9707008A MX9707008A MX9707008A MX 9707008 A MX9707008 A MX 9707008A MX 9707008 A MX9707008 A MX 9707008A MX 9707008 A MX9707008 A MX 9707008A MX 9707008 A MX9707008 A MX 9707008A
Authority
MX
Mexico
Prior art keywords
oestrogens
male contraceptives
contraceptives
male
invention concerns
Prior art date
Application number
MX9707008A
Other languages
English (en)
Other versions
MXPA97007008A (es
Inventor
Ursula Friederike Habenicht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9707008A publication Critical patent/MX9707008A/es
Publication of MXPA97007008A publication Critical patent/MXPA97007008A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Junction Field-Effect Transistors (AREA)

Abstract

La presente invencion se relaciona al uso de antiestrogenos (inhibidores de aromatasa, antagonistas del receptor del estrogeno) para preparar medicamentos contraceptivos para hombres.
MXPA/A/1997/007008A 1995-03-16 1997-09-12 Uso de antiestrogenos para control natal en hombres MXPA97007008A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19510862.0 1995-03-16
DE19510862A DE19510862A1 (de) 1995-03-16 1995-03-16 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
PCT/EP1996/001191 WO1996028154A2 (de) 1995-03-16 1996-03-15 Verwendung von antiestrogenen zur männlichen fertilitätskontrolle

Publications (2)

Publication Number Publication Date
MX9707008A true MX9707008A (es) 1997-11-29
MXPA97007008A MXPA97007008A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
DK0814803T3 (da) 2007-02-19
DE59611391D1 (de) 2006-11-23
AU713467B2 (en) 1999-12-02
CZ293771B6 (cs) 2004-07-14
AU5004696A (en) 1996-10-02
KR19980703057A (ko) 1998-09-05
SK284442B6 (sk) 2005-04-01
CN1178463A (zh) 1998-04-08
PT814803E (pt) 2007-02-28
CZ285297A3 (en) 1997-12-17
ES2275273T3 (es) 2007-06-01
HUP9900313A3 (en) 1999-11-29
NO974256L (no) 1997-11-14
CA2215373A1 (en) 1996-09-19
PL322253A1 (en) 1998-01-19
IL117515A (en) 2003-07-31
HUP9900313A1 (hu) 1999-06-28
EP0814803B1 (de) 2006-10-11
SK123897A3 (en) 1998-02-04
WO1996028154A2 (de) 1996-09-19
TW503106B (en) 2002-09-21
IL117515A0 (en) 1996-07-23
DE19510862A1 (de) 1996-09-19
NZ303672A (en) 2000-07-28
JPH11501648A (ja) 1999-02-09
CN1151792C (zh) 2004-06-02
ZA962176B (en) 1996-07-29
EP0814803A2 (de) 1998-01-07
NO974256D0 (no) 1997-09-15
WO1996028154A3 (de) 1997-05-01
US20010056086A1 (en) 2001-12-27
ATE342055T1 (de) 2006-11-15
PL186085B1 (pl) 2003-10-31

Similar Documents

Publication Publication Date Title
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
IL132153A0 (en) Novel compounds
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
EA200000492A1 (ru) Пероральные контрацептивы, содержащие антиэстроген плюс прогестин
BG102200A (en) Transcorneal system for the release of a medicament
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
SG188700A1 (en) Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
WO2000013650A3 (en) Neuroprotection
IL166432A0 (en) Composition containing an androgenous 11?-halogen steroid and a progestational hormone and male contraceptive based on said composition
HUP0102380A2 (hu) Terápiás készítmény hiperkalcémiás krízis kezelésére
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
MX9702381A (es) Medicamentos hormonales nuevos y su uso para corregir deficiencias de estrogeno.
WO1999029308A3 (de) Methode zur bekämpfung der fettleibigkeit
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO1996028154A3 (de) Verwendung von antiestrogenen zur männlichen fertilitätskontrolle
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
HUT41002A (en) Process for preparing anticonvulsives
AP2001002369A0 (en) Pharmaceutical complex.
BR9806210A (pt) Processos de contracepção masculina e para terapia de substituição de androgênio, contraceptivo masculino, e, forma de dosagem para a terapia de substituição de androgênio.
EP1025098A4 (en) BENTZOTHIOPHENE
AU7436098A (en) Use of mizolastine for preparing a medicine for treating inflammation
PT1365768E (pt) Utilização de antagonistas selectivos para er-beta como contraceptivos